A method to identify RNA A-to-I editing targets using I-specific cleavage and exon array analysis

Molecular and Cellular Probes

Volumn 27, Issue 1, 2013, Pages 38-45

  Tseng, Chao Neng ^a,b   Chang, Hsueh Wei ^a   Stocker, Joel ^a   Wang, Hui Chun ^a   Lu, Chiu Chin ^c   Wu, Cheng Hsuan ^d,e   Yang, Jyuer Ger ^c,d   Cho, Chung Lung ^c   Huang, Hurng Wern ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ADAR; Adenosine deamination; Exon array; I specific cleavage; Inosine; RNA editing

Indexed keywords

RNA;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CONTROLLED STUDY; EXON; GENETIC ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ADENOSINE TO INOSINE EDITING; RNA EDITING;

ANIMALS; BRAIN; CELL LINE; EXONS; GENOME; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; RECEPTORS, AMPA; RECEPTORS, GABA-A; RNA CLEAVAGE; RNA EDITING;

ANIMALIA; MUS;

EID: 84869864633     PISSN: 08908508     EISSN: 10961194     Source Type: Journal    
DOI: 10.1016/j.mcp.2012.08.008     Document Type: Article

References (60)

1. Bass B.L. How does RNA editing affect dsRNA-mediated gene silencing?. Cold Spring Harb Symp Quant Biol 2006, 71:285-292.
2. Bass B.L., Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988, 55:1089-1098.
3. Wagner R.W., Smith J.E., Cooperman B.S., Nishikura K. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc Natl Acad Sci U S A 1989, 86:2647-2651.
4. Kim U., Wang Y., Sanford T., Zeng Y., Nishikura K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci U S A 1994, 91:11457-11461.
5. Kim U., Garner T.L., Sanford T., Speicher D., Murray J.M., Nishikura K. Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J Biol Chem 1994, 269:13480-13489.
6. Chen C.X., Cho D.S., Wang Q., Lai F., Carter K.C., Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 2000, 6:755-767.
7. Basilio C., Wahba A.J., Lengyel P., Speyer J.F., Ochoa S. Synthetic polynucleotides and the amino acid code. V. Proc Natl Acad Sci U S A 1962, 48:613-616.
8. Nishikura K. Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol 2006, 7:919-931.
9. Paul M.S., Bass B.L. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J 1998, 17:1120-1127.
10. Sommer B., Kohler M., Sprengel R., Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 1991, 67:11-19.
11. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 1991, 253:1028-1031.
12. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992, 8:189-198.
13. Peng P.L., Zhong X., Tu W., Soundarapandian M.M., Molner P., Zhu D., et al. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 2006, 49:719-733.
14. Liu S., Lau L., Wei J., Zhu D., Zou S., Sun H.S., et al. Expression of Ca(2+)-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 2004, 43:43-55.
15. Higuchi M., Maas S., Single F.N., Hartner J., Rozov A., Burnashev N., et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
16. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004, 427:801.
17. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997, 387:303-308.
18. Price R.D., Weiner D.M., Chang M.S., Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem 2001, 276:44663-44668.
19. Niswender C.M., Copeland S.C., Herrick-Davis K., Emeson R.B., Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 1999, 274:9472-9478.
20. Niswender C.M., Herrick-Davis K., Dilley G.E., Meltzer H.Y., Overholser J.C., Stockmeier C.A., et al. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001, 24:478-491.
21. Schmauss C. Regulation of serotonin 2C receptor pre-mRNA editing by serotonin. Int Rev Neurobiol 2005, 63:83-100.
22. Grohmann M., Hammer P., Walther M., Paulmann N., Buttner A., Eisenmenger W., et al. Alternative splicing and extensive RNA editing of human TPH2 transcripts. PLoS One 2010, 5:e8956.
23. Ohlson J., Pedersen J.S., Haussler D., Ohman M. Editing modifies the GABA(A) receptor subunit alpha3. RNA 2007, 13:698-703.
24. Rula E.Y., Lagrange A.H., Jacobs M.M., Hu N., Macdonald R.L., Emeson R.B. Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci 2008, 28:6196-6201.
25. Nimmich M.L., Heidelberg L.S., Fisher J.L. RNA editing of the GABA(A) receptor alpha3 subunit alters the functional properties of recombinant receptors. Neurosci Res 2009, 63:288-293.
26. Daniel C., Wahlstedt H., Ohlson J., Bjork P., Ohman M. A-to-I RNA editing affects trafficking of the {gamma}-aminobutyric acid type A (GABAA) receptor. J Biol Chem 2010.
27. Hartner J.C., Schmittwolf C., Kispert A., Muller A.M., Higuchi M., Seeburg P.H. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004, 279:4894-4902.
28. Wang Q., Khillan J., Gadue P., Nishikura K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 2000, 290:1765-1768.
29. Wang Q., Miyakoda M., Yang W., Khillan J., Stachura D.L., Weiss M.J., et al. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004, 279:4952-4961.
30. XuFeng R., Boyer M.J., Shen H., Li Y., Yu H., Gao Y., et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A 2009, 106:17763-17768.
31. Iizasa H., Nishikura K. A new function for the RNA-editing enzyme ADAR1. Nat Immunol 2009, 10:16-18.
32. Rabinovici R., Kabir K., Chen M., Su Y., Zhang D., Luo X., et al. ADAR1 is involved in the development of microvascular lung injury. Circ Res 2001, 88:1066-1071.
33. Yang J.H., Luo X., Nie Y., Su Y., Zhao Q., Kabir K., et al. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 2003, 109:15-23.
34. Gan Z., Zhao L., Yang L., Huang P., Zhao F., Li W., et al. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells. J Biol Chem 2006, 281:33386-33394.
35. Singh M., Kesterson R.A., Jacobs M.M., Joers J.M., Gore J.C., Emeson R.B. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J Biol Chem 2007, 282:22448-22459.
36. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010, 79:321-349.
37. Xing Q., Wang M., Chen X., Qian X., Qin W., Gao J., et al. Identification of a novel ADAR mutation in a Chinese family with dyschromatosis symmetrica hereditaria (DSH). Arch Dermatol Res 2005, 297:139-142.
38. Miyamura Y., Suzuki T., Kono M., Inagaki K., Ito S., Suzuki N., et al. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 2003, 73:693-699.
39. Paz N., Levanon E.Y., Amariglio N., Heimberger A.B., Ram Z., Constantini S., et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 2007, 17:1586-1595.
40. Maas S., Patt S., Schrey M., Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A 2001, 98:14687-14692.
41. Cenci C., Barzotti R., Galeano F., Corbelli S., Rota R., Massimi L., et al. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 2008, 283:7251-7260.
42. Zhang F., Rabinovici R. Adenosine deaminase acting on RNA 1 accelerates cell cycle through increased translation and activity of cyclin-dependent kinase 2. Shock 2007, 27:214-219.
43. Hoopengardner B., Bhalla T., Staber C., Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science (New York, NY) 2003, 301:832-836.
44. Levanon E.Y., Hallegger M., Kinar Y., Shemesh R., Djinovic-Carugo K., Rechavi G., et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucl Acids Res 2005, 33:1162-1168.
45. Clutterbuck D.R., Leroy A., O'Connell M.A., Semple C.A. A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10. Bioinformatics (Oxford, England) 2005, 21:2590-2595.
46. Xia S., Yang J., Su Y., Qian J., Ma E., Haddad G.G. Identification of new targets of Drosophila pre-mRNA adenosine deaminase. Physiol Genomics 2005, 20:195-202.
47. Morse D.P., Bass B.L. Detection of inosine in messenger RNA by inosine-specific cleavage. Biochemistry 1997, 36:8429-8434.
48. Broude N.E., Budowsky E.I. The reaction of glyoxal with nucleic acid components. 3. Kinetics of the reaction with monomers. Biochim Biophys Acta 1971, 254:380-388.
49. Morse D.P., Bass B.L. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA. Proc Natl Acad Sci U S A 1999, 96:6048-6053.
50. Morse D.P., Aruscavage P.J., Bass B.L. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc Natl Acad Sci U S A 2002, 99:7906-7911.
51. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001, 98:31-36.
52. Morse D.P. Identification of substrates for adenosine deaminases that act on RNA. Meth Mol Biol (Clifton, NJ) 2004, 265:199-218.
53. Hoopengardner B., Bhalla T., Staber C., Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 2003, 301:832-836.
54. Neeman Y., Levanon E.Y., Jantsch M.F., Eisenberg E. RNA editing level in the mouse is determined by the genomic repeat repertoire. RNA 2006, 12:1802-1809.
55. Kiran A., Baranov P.V. DARNED: a database of RNA editing in humans. Bioinformatics 2010, 26:1772-1776.
56. Ohlson J., Enstero M., Sjoberg B.M., Ohman M. A method to find tissue-specific novel sites of selective adenosine deamination. Nucl Acids Res 2005, 33:e167.
57. Struhalla M., Czaja R., Hahn U. Addressing the challenge of changing the specificity of RNase T1 with rational and evolutionary approaches. Chembiochem 2004, 5:200-205.
58. Li J.B., Levanon E.Y., Yoon J.K., Aach J., Xie B., Leproust E., et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009, 324:1210-1213.
59. Sakurai M., Yano T., Kawabata H., Ueda H., Suzuki T. Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome. Nat Chem Biol 2010, 6:733-740.
60. Li M., Wang I.X., Li Y., Bruzel A., Richards A.L., Toung J.M., et al. Widespread RNA and DNA sequence differences in the human transcriptome. Science (New York, NY) 2011, 333:53-58.